Ładuje się......
An Engineered Factor Va Prevents Bleeding Induced by Anticoagulant wt Activated Protein C
OBJECTIVE: An increased risk of bleeding is observed in patients receiving activated protein C (APC), which may be a limiting factor for the application of novel APC therapies. Since APC's therapeutic effects often require its cytoprotective activities on cells but not APC's anticoagulant...
Zapisane w:
| Główni autorzy: | , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Public Library of Science
2014
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4134195/ https://ncbi.nlm.nih.gov/pubmed/25127130 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0104304 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|